|
|
|
|
|
|
|
|
VOLUME 31: NO. 10 OCTOBER
2004
Editorial
Power of the Database: An
International Approach to Studying Longterm
Rheumatoid Arthritis Therapy
The Evolving Use of Tumor Necrosis
Factor Inhibitors in Rheumatoid Arthritis
Tumor Necrosis Factor-a Blockade and the Risk of
Vasculitis
Mechanisms of Action of Tumor
Necrosis Factor Antagonists and Granulomatous
Infections
Topical Nonsteroidal
Antiinflammatory Drugs Are Effective in
Osteoarthritis of the Knee Articles
Fatigue Assessments in RA:
Comparative Performance of Visual Analog Scales and
Longer Fatigue Questionnaires in 7760
Patients
Can Gold Therapy Be Used More
Safely in RA? Adverse Drug Reactions Are More Likely
in Patients with Nodular Disease, Independent of
HLA-DR3 Status
Adverse Events with DMARD: A Cohort
Study of Leflunomide Compared with Other
DMARD
Infusion-Related Reactions to
Infliximab in Patients with RA in a Clinical Practice
Setting: Relationship to Dose, Antihistamine
Pretreatment, and Infusion Number
Multisegment Foot Motion During
Gait: Proof of Concept in RA
Occupational Risk Factors for the
Development of SLE
The Systemic Lupus Activity
Measure-Revised, the Mexican SLE Disease Activity
Index (SLEDAI), and a Modified SLEDAI-2K Are Adequate
Instruments to Measure Disease Activity in
SLE
High Prevalence of Right
Ventricular Systolic Dysfunction in Early Systemic
Sclerosis
Autocrine Activation by
IL-1a Induces the
Fibrogenic Phenotype of SSc Fibroblasts
Leukocytoclastic Vasculitis
Associated with TNF-a
Blocking Agents
Analysis of CARD15 Polymorphisms in
Korean Patients with AS Reveals Absence of Common
Variants Seen in Western Populations
CD8+ T Cells Oligoclonally Expanded
in Synovial Fluid at Onset of SpA Selectively
Proliferate in Response to Self-Antigens:
Characterization of Cell Specificities in Nonclonal
Populations
Doxycycline versus Doxycycline and
Rifampin in Undifferentiated SpA, with Special
Reference to Chlamydia-Induced Arthritis. A
Prospective, Randomized 9-Month Comparison
Clinical Vertebral Fractures in
Patients with AS
Increasing Mineral Density After
Menopause in Individual Lumbar Vertebrae as a Marker
for Incident Degenerative Disease: A Pilot Study for
the Effects of Body Composition and Diet
Are There Differences Between Men
and Women Prescribed Bisphosphonate Therapy in
Canadian Subspecialty Osteoporosis
Practices?
Comparing the AUSCAN OA Hand Index,
Michigan Hand Outcomes Questionnaire, and Sequential
Occupational Dexterity Assessment for Patients with
RA
Equivalence Study of a Topical
Diclofenac Solution (Pennsaid®) Compared
with Oral Diclofenac in Symptomatic Treatment of OA
of the Knee: A Randomized Controlled Trial
Osteoarthritic Mice Exhibit
Enhanced PGE2 and Unchanged CGRP Release
in a Novel Isolated Knee Joint Model
Tenascin-C Concentration in
Synovial Fluid Correlates with Radiographic
Progression of Knee OA
Inflammatory Markers and Physical
Function Among Older Adults with Knee OA
The Prevalence of Diffuse
Idiopathic Skeletal Hyperostosis in Korea
Interrelations Between FM, Thyroid
Autoantibodies, and Depression
Workshop Report: Clinical
Diagnosis and Imaging of Sacroiliitis, Innsbruck,
Austria, October 9, 2003 Pediatric Rheumatology
Cytokine Flexibility of Early and
Differentiated Memory T Helper Cells in JIA
Prolonged Efficacy of Etanercept in
Refractory Enthesitis-Related Arthritis
Polymorphisms in the Promoter
Region of RANTES and the Regulatory Region of MCP-1
Among Chinese Children with SLE
Favorable Outcome in Patients with
Renal Involvement Complicating Macrophage Activation
Syndrome in Systemic Onset JRA
Effective Use of the Recombinant
IL-1 Receptor Antagonist Anakinra in Therapy
Resistant Systemic Onset JRA Case Reports
Vasculitis Associated with the Use
of Leflunomide
Sensory Neuropathy Revealing
Necrotizing Vasculitis During Infliximab Therapy for
RA
Alpha1-Antitrypsin
Replacement Therapy Controls FM Symptoms in 2
Patients with PI ZZ Alpha1-Antitrypsin
Deficiency Images in Rheumatology
Bone Resorption in Systemic
Sclerosis (Scleroderma)
Autoamputation in a Patient with
Cryoglobulinemia
Correspondence Raynaud's Phenomenon and Serotonin Reuptake Inhibitors C. Garcia-Porrua, C. Canedo Margariños, M.A. Gonzalez-Gay.........2090 Reply E. Matsuura, A. Ohta, R. Sherriff-Tadano .........2090 Erectile Dysfunction and Scleroderma S.R. Johnson, C. Dewar.........2091 Reply J. Pope, J. Ouimet .........2091
Notices
|
